-
Veritone Inc. (VERI $4.99)
- $4.99 Cap: $305M
- View VERI Profile
- View Questions on VERI
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Veritone Inc. (VERI $4.99)
- $4.99 Cap: $305M
- View VERI Profile
- View Questions on VERI
Q: Why the sudden rise today? Would you consider this a buy, sell or hold?
Thank you as always!!
Thank you as always!!
-
Veritone Inc. (VERI $4.99)
- $4.99 Cap: $305M
- View VERI Profile
- View Questions on VERI
Q: Your thoughts on initiating a small position at this time? Any future activity would follow a wait and see approach. Thank you.
-
Exelixis Inc. (EXEL $38.73)
- $38.73 P/E (TTM): 17.42X Cap: $10.27B
- View EXEL Profile
- View Questions on EXEL
-
TG Therapeutics Inc. (TGTX $34.06)
- $34.06 P/E (TTM): 153.45X Cap: $5.67B
- View TGTX Profile
- View Questions on TGTX
-
Veritone Inc. (VERI $4.99)
- $4.99 Cap: $305M
- View VERI Profile
- View Questions on VERI
-
Agora Inc. (API $3.60)
- $3.60 Cap: $379M
- View API Profile
- View Questions on API
-
Atomera Incorporated (ATOM $4.71)
- $4.71 Cap: $157M
- View ATOM Profile
- View Questions on ATOM
-
Affirm Holdings Inc. (AFRM $73.59)
- $73.59 P/E (TTM): 592.83X Cap: $23.16B
- View AFRM Profile
- View Questions on AFRM
Q: (Part 2 with 6 new companies) I watched a presentation on Saturday where analysts fielded audience company suggestions and whittled them down to a few that they felt could 10 X in a reasonable time frame. I am wondering if you can look at this six and rank based on potential? For the top two, it would be great if you can discuss the TAM, impact of market value and shares outstanding, if they are solving a new problem/creating a new market and quality of management. Basically, why those two?
ATOM
API
AFRM
VERI
TGTX
EXEL
ATOM
API
AFRM
VERI
TGTX
EXEL
Insiders
Share Information
SEC Filings
News and Media